BWXTのチャート
BWXTの企業情報
| symbol | BWXT |
|---|---|
| 会社名 | BWX Technologies inc （BWX TECHNOLOGIES） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | 航空宇宙_防衛 工業（Industrials） |
| 概要 | ザ・バブコック・アンド・ウィルコックス（The Babcock_Wilcox Company）は発電システムの技術革新、核成分の専門建設及び自社業務へのサービス提供に集中する会社である。同社は電気公益事業者とその他発電者を含む電力・その他蒸気使用産業の顧客、その他産業の法人顧客、並びに米国政府に多様な製品・サービスを提供する。同社は発電、原子力業務、技術サービス及び核エネルギーという4つの事業区分により構成される。平成23年11月に、同社の発電事業に属するある子会社はマテリアル・ハンドリング設備を製造するAnlagenbau und Fordertechnik Arthur Loibl GmbHを買収した。 バブコック・アンド・ウィルコックスは、米国の総合エンジニアリング企業。米国政府および、電力・蒸気関連産業分野向けに製品とサ―ビスを提供する。主要製品およびサ―ビスは、化石燃料や再生可能燃料で点火するボイラ―、環境機器および関連サ―ビス、海軍向け核成分と原子炉、ウラン処理および環境復元サ―ビス、商業用原子力蒸気発生器など。 Headquartered in Lynchburg, Virginia, BWX Technologies Inc. provides safe and effective nuclear solutions for national security, clean energy, environmental remediation, nuclear medicine and space exploration. With approximately 6,700 employees, BWXT has 12 major operating sites in the U.S. and Canada. In addition, BWXT joint ventures provide management and operations at more than a dozen U.S. Department of Energy and NASA facilities. |
| 本社所在地 | 800 Main Street 4th Floor Lynchburg VA 24504 USA |
| 代表者氏名 | Rex D. Geveden |
| 代表者役職名 | President Chief Executive Officer Director |
| 電話番号 | +1 980-365-4300 |
| 設立年月日 | 1867年 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | 6250人 |
| url | www.bwxt.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | （百万ドル） 334.96200 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | （百万ドル） 4842.41300 |
| 売上高 | （百万ドル） 1799.88900 |
| 企業価値(EV) | （百万ドル） 5576.78900 |
| 当期純利益 | （百万ドル） 213.45800 |
| 決算概要 | BRIEF: For the fiscal year ended 31 December 2018 BWX Technologies Inc revenues increased 7% to $1.8B. Net income before extraordinary items increased 6% to $213.5M. Revenues reflect Nuclear Power Group segment increase of 28% to $365.9M Nuclear operations segment increase of 4% to $1.32B Canada segment increase of 20% to $294.9M United States segment increase of 3% to $1.45B China segment increase of 65% to $43.4M. |
BWXTのテクニカル分析
BWXTのニュース
New filing by BWX TECHNOLOGIES, INC POLITICAL ACTION COMMITTEE 2022/07/15 15:29:18 The FEC
The BWX TECHNOLOGIES, INC POLITICAL ACTION COMMITTEE successfully filed their F3XN JULY MONTHLY with the coverage period of 06/01/2022 to 06/30/2022 and a confirmation ID of FEC-1612735 *********CommitteeId: C00365502 | FilingId: 1612735 | FormType: F3XN | CoverageFrom: 06/01/2022 | CoverageThrough: 06/30/2022 | ReportType: JULY MONTHLY*********
BWX Technologies to Announce Second Quarter 2022 Results on Monday, August 8 2022/07/14 12:00:00 Business Wire
LYNCHBURG, Va.--(BUSINESS WIRE)---- $BWXT #earnings--BWX Technologies, Inc. (BWXT) (NYSE: BWXT) will issue a press release detailing second quarter 2022 results on Monday, August 8, 2022, after market close and will host a conference call at 5:00 p.m. EDT. Listen-only participants are encouraged to participate and view the supporting presentation via the Internet at www.bwxt.com/investors. The dial-in numbers for participants are (U.S.) 844-200-6205 and (International) 929-526-1599; access code: 875922. A replay o
BWX Technologies'' Canada operations awarded C$130M contract from Bruce Power 2022/07/05 11:05:09 Seeking Alpha
BWX Technologies (BWXT) received a contract worth ~$C$130M from Bruce Power for supporting Bruce Power''s Major Component Replacement Project.The contract is for the fabrication and…
BWXT Canada Awarded CA$130 Million Component Manufacturing Contract from Bruce Power 2022/07/05 10:45:00 Wallstreet:Online
BWX Technologies, Inc. (NYSE: BWXT) today announced a contract awarded by Bruce Power valued at approximately CA$130 million in support of Bruce Power’s Major Component Replacement (MCR) Project. The contract is for the fabrication and supply of replacement feeders for Bruce Power’s reactor units 3, 4, 5, 7 and 8 and represents an integral part of Bruce Power’s MCR Project. Feeder tube
BWXT Medical, Bayer Ink Commercial Agreement For Actinium-225 Based Products 2022/06/27 14:20:45 Benzinga
BWX Technologies Inc (NYSE: BWXT ) subsidiary BWXT Medical Ltd. has entered a commercial agreement with Bayer AG (OTC: BAYRY ) to supply high-purity Actinium-225 (Ac-225). Bayer will purchase high-purity Ac-225 from BWXT Medical at pre-determined prices. The … Full story available on Benzinga.com
BofA Bumps Up BWX Technologies Price Target By 18% 2022/03/16 19:07:56 Benzinga
BWX Technologies Inc (NYSE: BWXT ) price target has been raised to $65 (an upside of 25%) from $55 by BofA analyst Ronald Epstein, who expects BWXT to continue benefiting from increased defense spending and a greater emphasis on … Full story available on Benzinga.com
BWX Technologies goes ex-dividend tomorrow 2022/03/08 15:53:53 Seeking Alpha
BWX Technologies (BWXT) had declared $0.22/share quarterly dividend, 4.8% increase from prior dividend of $0.21. Payable March 29; for shareholders of record March 10; ex-div March 9.
BWX Technologies (BWXT) Q4 2021 Earnings Call Transcript 2022/02/23 04:00:35 The Motley Fool
BWXT earnings call for the period ending December 31, 2021.
BWX Technologies, Inc. (BWXT) CEO Rex Geveden on Q4 2021 Earnings Call Transcript 2022/02/23 03:39:09 Seeking Alpha
BWX Technologies goes ex-dividend tomorrow 2022/03/08 15:53:53 Seeking Alpha
BWX Technologies (BWXT) had declared $0.22/share quarterly dividend, 4.8% increase from prior dividend of $0.21. Payable March 29; for shareholders of record March 10; ex-div March 9.
BWX Technologies (BWXT) Q4 2021 Earnings Call Transcript 2022/02/23 04:00:35 The Motley Fool
BWXT earnings call for the period ending December 31, 2021.
BWX Technologies, Inc. (BWXT) CEO Rex Geveden on Q4 2021 Earnings Call Transcript 2022/02/23 03:39:09 Seeking Alpha
BWX Technologies, Inc. 2021 Q4 - Results - Earnings Call Presentation 2022/02/22 22:28:30 Seeking Alpha
BWX Technologies Non-GAAP EPS of $0.95 beats by $0.02, revenue of $592M misses by $10.37M (NYSE:BWXT) 2022/02/22 21:22:18 Seeking Alpha
BWX Technologies press release (BWXT): Q4 Non-GAAP EPS of $0.95 beats by $0.02.Revenue of $592M (+6.3% Y/Y) misses by $10.37M.Produces 4Q21 adjusted EBITDA of $123 million,